Identity
HGNC
LOCATION
10q24.2
LOCUSID
ALIAS
ABC30,CMOAT,DJS,MRP2,cMRP
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 1244
MIM: 601107
HGNC: 53
Ensembl: ENSG00000023839
Variants:
dbSNP: 1244
ClinVar: 1244
TCGA: ENSG00000023839
COSMIC: ABCC2
RNA/Proteins
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
PharmGKB
| Entity ID | Name | Type | Evidence | Association | PK | PD | PMIDs |
|---|---|---|---|---|---|---|---|
| PA10204 | tenofovir | Chemical | ClinicalAnnotation | associated | PD | 17083032, 19400747, 25485598, 26287941, 26535588, 26807589, 31619748 | |
| PA10251 | atazanavir | Chemical | ClinicalAnnotation | associated | PD | 26287941 | |
| PA10804 | imatinib | Chemical | ClinicalAnnotation | associated | PD | 30237583 | |
| PA10810 | pemetrexed | Chemical | ClinicalAnnotation | associated | PD | ||
| PA128406956 | fluorouracil | Chemical | ClinicalAnnotation | associated | PD | 23314736 | |
| PA131285527 | oxaliplatin | Chemical | ClinicalAnnotation | associated | PD | 23314736 | |
| PA132595336 | calcein | Chemical | ClinicalAnnotation, VariantAnnotation | associated | PK | 22027652 | |
| PA133888799 | Organ Transplantation | Disease | ClinicalAnnotation | associated | PK | 25163792 | |
| PA133950441 | hmg coa reductase inhibitors | Chemical | Pathway | associated | |||
| PA134308647 | rosuvastatin | Chemical | VariantAnnotation | associated | PK | 30100615 | |
| PA142650384 | pitavastatin | Chemical | ClinicalAnnotation | associated | PK | 23007012 | |
| PA143485705 | antiepileptics | Chemical | ClinicalAnnotation, Literature, MultilinkAnnotation | associated | PK | PD | 21449672, 21799461, 22188362, 22256867, 22630058, 23697249, 24567120, 24624913, 25155934, 27816260 |
| PA146123005 | talinolol | Chemical | ClinicalAnnotation | associated | 18334920 | ||
| PA151958383 | Gastrointestinal Stromal Tumors | Disease | ClinicalAnnotation | associated | PD | 30237583 | |
| PA164712708 | Drugs For Treatment Of Tuberculosis | Chemical | ClinicalAnnotation | associated | PD | 31648372 | |
| PA164713176 | Platinum compounds | Chemical | Pathway | associated | 19525887 | ||
| PA164748728 | mycophenolic acid | Chemical | ClinicalAnnotation | associated | PK | 25163792, 28624888 | |
| PA164760843 | deferasirox | Chemical | ClinicalAnnotation | associated | PK | PD | 25348619, 26403473 |
| PA164925725 | Toxic liver disease | Disease | ClinicalAnnotation | associated | PD | 31648372 | |
| PA165110775 | SN-38 | Chemical | Pathway | associated | |||
| PA165817016 | Kidney Transplantation | Disease | ClinicalAnnotation | associated | PK | 25163792, 28316087, 28624888, 29318894 | |
| PA378 | NR1I2 | Gene | Pathway | associated | 21151855 | ||
| PA443421 | Arrhythmias, Cardiac | Disease | ClinicalAnnotation | associated | PK | PD | 16330681 |
| PA443434 | Arthritis, Rheumatoid | Disease | ClinicalAnnotation | associated | PD | 18381794, 27217051 | |
| PA443560 | Breast Neoplasms | Disease | ClinicalAnnotation | associated | PK | PD | |
| PA443622 | Carcinoma, Non-Small-Cell Lung | Disease | ClinicalAnnotation | associated | PD | 18221820 | |
| PA443658 | Central Nervous System Infections | Disease | ClinicalAnnotation | associated | PK | 29873816 | |
| PA443756 | Colonic Neoplasms | Disease | ClinicalAnnotation | associated | PD | 23314736 | |
| PA443937 | Drug Toxicity | Disease | ClinicalAnnotation | associated | PK | PD | 16330681 |
| PA444065 | Epilepsy | Disease | ClinicalAnnotation | associated | PK | PD | 20216337, 21449672, 21799461, 22188362, 22256867, 22630058, 23252947, 23697249, 24567120, 25155934, 27816260 |
| PA444109 | Exanthema | Disease | ClinicalAnnotation | associated | PD | 23237922 | |
| PA444516 | Hypercholesterolemia | Disease | ClinicalAnnotation | associated | PD | 29178257 | |
| PA444682 | Kidney Diseases | Disease | ClinicalAnnotation | associated | PD | 17083032, 19400747, 25485598, 26535588, 26807589 | |
| PA444756 | Leukemia, Lymphoid | Disease | ClinicalAnnotation | associated | PK | 23069858, 24241962, 29791011 | |
| PA444845 | Lymphoma, Non-Hodgkin | Disease | ClinicalAnnotation | associated | PK | PD | 16330681 |
| PA444937 | Mesothelioma | Disease | ClinicalAnnotation | associated | PD | ||
| PA445941 | Tuberculosis | Disease | ClinicalAnnotation | associated | PD | 31648372 | |
| PA446108 | Colorectal Neoplasms | Disease | ClinicalAnnotation | associated | PK | PD | 18981587 |
| PA446155 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Disease | ClinicalAnnotation | associated | PK | PD | 24241962 |
| PA446157 | Leukemia, B-Cell, Acute | Disease | ClinicalAnnotation | associated | PK | PD | 23222202 |
| PA446432 | beta-Thalassemia | Disease | ClinicalAnnotation | associated | PK | PD | 25348619, 26403473 |
| PA447230 | HIV Infections | Disease | ClinicalAnnotation | associated | PK | PD | 17083032, 19400747, 19842932, 22027652, 25485598, 26535588, 26774523, 26807589, 31619748 |
| PA448500 | atorvastatin | Chemical | ClinicalAnnotation, Pathway | associated | PD | 22186618, 29178257 | |
| PA448785 | carbamazepine | Chemical | ClinicalAnnotation, Pathway | associated | PK | PD | 20216337, 21449672, 21738081, 21799461, 22188362, 22256867, 22630058, 23252947, 23697249, 24567120, 25155934 |
| PA448866 | ceftriaxone | Chemical | ClinicalAnnotation | associated | PK | 29873816 | |
| PA449014 | cisplatin | Chemical | ClinicalAnnotation | associated | PD | ||
| PA449165 | cyclophosphamide | Chemical | ClinicalAnnotation | associated | PD | ||
| PA449167 | cyclosporine | Chemical | ClinicalAnnotation | associated | PK | 25163792, 28624888 | |
| PA449383 | docetaxel | Chemical | ClinicalAnnotation, Pathway | associated | PK | PD | 18294295, 21151855, 23188068 |
| PA449412 | doxorubicin | Chemical | ClinicalAnnotation | associated | PK | PD | 16330681 |
| PA449441 | efavirenz | Chemical | ClinicalAnnotation | associated | PK | 26774523 | |
| PA449493 | erythromycin | Chemical | ClinicalAnnotation | associated | PK | ||
| PA450085 | irinotecan | Chemical | ClinicalAnnotation, Pathway | associated | PK | PD | 18221820, 18981587 |
| PA450163 | lamivudine | Chemical | Pathway | associated | |||
| PA450198 | leucovorin | Chemical | ClinicalAnnotation | associated | PD | 23314736 | |
| PA450264 | lopinavir | Chemical | ClinicalAnnotation, VariantAnnotation | associated | PK | PD | 19842932, 22027652, 26287941 |
| PA450272 | lovastatin | Chemical | Pathway | associated | |||
| PA450428 | methotrexate | Chemical | ClinicalAnnotation, Pathway | associated | PK | PD | 18381794, 21317831, 23069858, 23222202, 24241962, 25502615, 27217051, 29791011 |
| PA450732 | oxcarbazepine | Chemical | ClinicalAnnotation | associated | PK | PD | 21449672, 21799461, 22188362, 22256867, 22630058, 23697249, 24567120, 25155934 |
| PA450761 | paclitaxel | Chemical | Pathway | associated | 21151855 | ||
| PA451089 | pravastatin | Chemical | ClinicalAnnotation, Pathway | associated | PK | 17047488 | |
| PA451260 | ritonavir | Chemical | ClinicalAnnotation | associated | PD | 26287941 | |
| PA451363 | simvastatin | Chemical | ClinicalAnnotation, Pathway | associated | PD | 22186618 | |
| PA451578 | tacrolimus | Chemical | ClinicalAnnotation | associated | PK | 28316087, 29318894 | |
| PA451581 | tamoxifen | Chemical | ClinicalAnnotation | associated | PK | PD | |
| PA451879 | vincristine | Chemical | Pathway | associated | |||
| PA7000 | sorafenib | Chemical | ClinicalAnnotation | associated | PD | 23237922 |
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 38316776 | 2024 | Transport mechanism of human bilirubin transporter ABCC2 tuned by the inter-module regulatory domain. | 2 |
| 38316776 | 2024 | Transport mechanism of human bilirubin transporter ABCC2 tuned by the inter-module regulatory domain. | 2 |
| 36253887 | 2023 | Impact of ABCC2 1249G>A and -24C>T Polymorphisms on Lacosamide Efficacy and Plasma Concentrations in Uygur Pediatric Patients With Epilepsy in China. | 1 |
| 36274106 | 2023 | Concurrence of novel mutations causing Gilbert's and Dubin-Johnson syndrome with poor clinical outcomes in a Han Chinese family. | 0 |
| 36463535 | 2023 | Effects of splicing-regulatory polymorphisms in ABCC2, ABCG2, and ABCB1 on methotrexate exposure in Chinese children with acute lymphoblastic leukemia. | 1 |
| 36507589 | 2023 | Genetic variations in ABC transporter genes as a predictive biomarker for toxicity in North Indian lung cancer patients undergoing platinum-based doublet chemotherapy. | 0 |
| 36537755 | 2023 | Association Between ABCG2, ABCB1, ABCC2 Efflux Transporter Single-Nucleotide Variants and Irinotecan Adverse Effects in Patients With Colorectal Cancer: A Real-Life Study. | 1 |
| 36253887 | 2023 | Impact of ABCC2 1249G>A and -24C>T Polymorphisms on Lacosamide Efficacy and Plasma Concentrations in Uygur Pediatric Patients With Epilepsy in China. | 1 |
| 36274106 | 2023 | Concurrence of novel mutations causing Gilbert's and Dubin-Johnson syndrome with poor clinical outcomes in a Han Chinese family. | 0 |
| 36463535 | 2023 | Effects of splicing-regulatory polymorphisms in ABCC2, ABCG2, and ABCB1 on methotrexate exposure in Chinese children with acute lymphoblastic leukemia. | 1 |
| 36507589 | 2023 | Genetic variations in ABC transporter genes as a predictive biomarker for toxicity in North Indian lung cancer patients undergoing platinum-based doublet chemotherapy. | 0 |
| 36537755 | 2023 | Association Between ABCG2, ABCB1, ABCC2 Efflux Transporter Single-Nucleotide Variants and Irinotecan Adverse Effects in Patients With Colorectal Cancer: A Real-Life Study. | 1 |
| 34958810 | 2022 | ABCC2 expression in papillary renal cell carcinoma provides better prognostic stratification than WHO/ISUP nucleolar grade. | 2 |
| 35325436 | 2022 | The ABCB1, ABCC2 and RALBP1 polymorphisms are associated with carbamazepine response in epileptic patient: a systematic review. | 1 |
| 35477852 | 2022 | In silico screening and analysis of single-nucleotide polymorphic variants of the ABCC2 gene affecting Dubin-Johnson syndrome. | 1 |
Citation
Dessen P
ABCC2 (ATP binding cassette subfamily C member 2)
Atlas Genet Cytogenet Oncol Haematol. 2003-02-01
Online version: http://atlasgeneticsoncology.org/gene/539/abcc2
